Gujarat Kidney And Super Speciality Limited has informed the Exchange about intimation of receipt of Notice for non compliance with Regulation 29(2)/29(3) of SEBI (LODR) Regulations, 2015
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Kidney And Super Speciality Limited has been fined Rs. 10,000 each (plus GST) by both NSE and BSE for failing to give prior intimation about a meeting of the Board of Directors as required under Regulation 29(2)/29(3) of SEBI (LODR) Regulations, 2015. The notices were received on April 15, 2026, and the company has stated it will pay the fines within the timelines prescribed by the exchanges. The total financial impact is approximately Rs. 23,600 (Rs. 20,000 in basic fines plus GST on both). The company has clarified that there is no impact on its financial, operational, or other activities due to these fines.
This is a minor compliance-related penalty with negligible financial impact. It is a procedural lapse in disclosure timing and is unlikely to affect the stock price or shareholder value, though it signals weak internal compliance processes.